TY - JOUR
KW - Ozempic
KW - Erythema Nodosum
KW - semaglutide
AU - Sobieraj J
AU - Schapiro B
AU - Nasir W
BT - JAAD case reports
C1 - https://www.ncbi.nlm.nih.gov/pubmed/38689866
DA - 05/2024
DO - 10.1016/j.jdcr.2024.02.014
J2 - JAAD Case Rep
LA - ENG
M3 - Case Report
PY - 2024
SP - 90
EP - 92
T2 - JAAD case reports
TI - Dose-dependent erythema nodosum after initiation of semaglutide.
UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC11058707/pdf/main.pdf
VL - 47
SN - 2352-5126
ER -